CagriSema Dual Pathway Metabolic Signaling Compound CagriSema combines two investigational molecules Cagrilintide (amylin analogue) and Semaglutide (GLP 1 receptor agonist), designed to influence key metabolic and appetite regulating pathways. Current Cagrilintide Lumin Peptides Development of Cagrilintide, a Long Acting Amylin Analogue Journal of Medicinal Chemistry Hien Interested in evolving your weight loss journey? Jump start that shot again! Have you heard about Cagrilintide? This amylin analog is being investigated for its potential role in supporting weight Structural and mechanistic insights into dual activation of cagrilintide in amylin and calcitonin receptors Acta Pharmacologica Sinica Cagrilintide side effects: what the clinical trials actually show SeekPeptides